Cargando…
Cellular model system to dissect the isoform-selectivity of Akt inhibitors
The protein kinase Akt plays a pivotal role in cellular processes. However, its isoforms’ distinct functions have not been resolved to date, mainly due to the lack of suitable biochemical and cellular tools. Against this background, we present the development of an isoform-dependent Ba/F3 model syst...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421423/ https://www.ncbi.nlm.nih.gov/pubmed/34489430 http://dx.doi.org/10.1038/s41467-021-25512-8 |
_version_ | 1783749080252416000 |
---|---|
author | Quambusch, Lena Depta, Laura Landel, Ina Lubeck, Melissa Kirschner, Tonia Nabert, Jonas Uhlenbrock, Niklas Weisner, Jörn Kostka, Michael Levy, Laura M. Schultz-Fademrecht, Carsten Glanemann, Franziska Althoff, Kristina Müller, Matthias P. Siveke, Jens T. Rauh, Daniel |
author_facet | Quambusch, Lena Depta, Laura Landel, Ina Lubeck, Melissa Kirschner, Tonia Nabert, Jonas Uhlenbrock, Niklas Weisner, Jörn Kostka, Michael Levy, Laura M. Schultz-Fademrecht, Carsten Glanemann, Franziska Althoff, Kristina Müller, Matthias P. Siveke, Jens T. Rauh, Daniel |
author_sort | Quambusch, Lena |
collection | PubMed |
description | The protein kinase Akt plays a pivotal role in cellular processes. However, its isoforms’ distinct functions have not been resolved to date, mainly due to the lack of suitable biochemical and cellular tools. Against this background, we present the development of an isoform-dependent Ba/F3 model system to translate biochemical results on isoform specificity to the cellular level. Our cellular model system complemented by protein X-ray crystallography and structure-based ligand design results in covalent-allosteric Akt inhibitors with unique selectivity profiles. In a first proof-of-concept, the developed molecules allow studies on isoform-selective effects of Akt inhibition in cancer cells. Thus, this study will pave the way to resolve isoform-selective roles in health and disease and foster the development of next-generation therapeutics with superior on-target properties. |
format | Online Article Text |
id | pubmed-8421423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84214232021-09-22 Cellular model system to dissect the isoform-selectivity of Akt inhibitors Quambusch, Lena Depta, Laura Landel, Ina Lubeck, Melissa Kirschner, Tonia Nabert, Jonas Uhlenbrock, Niklas Weisner, Jörn Kostka, Michael Levy, Laura M. Schultz-Fademrecht, Carsten Glanemann, Franziska Althoff, Kristina Müller, Matthias P. Siveke, Jens T. Rauh, Daniel Nat Commun Article The protein kinase Akt plays a pivotal role in cellular processes. However, its isoforms’ distinct functions have not been resolved to date, mainly due to the lack of suitable biochemical and cellular tools. Against this background, we present the development of an isoform-dependent Ba/F3 model system to translate biochemical results on isoform specificity to the cellular level. Our cellular model system complemented by protein X-ray crystallography and structure-based ligand design results in covalent-allosteric Akt inhibitors with unique selectivity profiles. In a first proof-of-concept, the developed molecules allow studies on isoform-selective effects of Akt inhibition in cancer cells. Thus, this study will pave the way to resolve isoform-selective roles in health and disease and foster the development of next-generation therapeutics with superior on-target properties. Nature Publishing Group UK 2021-09-06 /pmc/articles/PMC8421423/ /pubmed/34489430 http://dx.doi.org/10.1038/s41467-021-25512-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Quambusch, Lena Depta, Laura Landel, Ina Lubeck, Melissa Kirschner, Tonia Nabert, Jonas Uhlenbrock, Niklas Weisner, Jörn Kostka, Michael Levy, Laura M. Schultz-Fademrecht, Carsten Glanemann, Franziska Althoff, Kristina Müller, Matthias P. Siveke, Jens T. Rauh, Daniel Cellular model system to dissect the isoform-selectivity of Akt inhibitors |
title | Cellular model system to dissect the isoform-selectivity of Akt inhibitors |
title_full | Cellular model system to dissect the isoform-selectivity of Akt inhibitors |
title_fullStr | Cellular model system to dissect the isoform-selectivity of Akt inhibitors |
title_full_unstemmed | Cellular model system to dissect the isoform-selectivity of Akt inhibitors |
title_short | Cellular model system to dissect the isoform-selectivity of Akt inhibitors |
title_sort | cellular model system to dissect the isoform-selectivity of akt inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421423/ https://www.ncbi.nlm.nih.gov/pubmed/34489430 http://dx.doi.org/10.1038/s41467-021-25512-8 |
work_keys_str_mv | AT quambuschlena cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT deptalaura cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT landelina cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT lubeckmelissa cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT kirschnertonia cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT nabertjonas cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT uhlenbrockniklas cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT weisnerjorn cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT kostkamichael cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT levylauram cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT schultzfademrechtcarsten cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT glanemannfranziska cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT althoffkristina cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT mullermatthiasp cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT sivekejenst cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors AT rauhdaniel cellularmodelsystemtodissecttheisoformselectivityofaktinhibitors |